The MutexaGPT multi-agent large language model system translated a cold-adaptation design request into molecular simulations and linker-variant proposals for bidomain amylase. The authors report experimentally validated variants with 1.7-fold and 3.7-fold activity enhancement at 0 °C. The preprint appeared on 19 June 2026; the peer-reviewed journal version followed on 10 September 2026.
Technology: Multi-agent large language model system coordinating high-throughput molecular dynamics simulations and mutation design
Publication: Preprint · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Preprint
- Test type: direct test
- Tested: The primary article reports two MutexaGPT-guided bidomain amylase linker variants with experimentally measured 1.7-fold and 3.7-fold activity enhancement at 0 °C. The Methods define relative activity using the 0 °C to 45 °C activity ratio.
- Still unknown: The experimental result is specific to the tested bidomain amylase and variants; broader enzyme-family transfer and independent reproduction are not established.
- AI role: LLM agents clarify the design request, translate it into computational plans and mutation patterns, and explain simulation outputs. High-throughput molecular dynamics metrics guide the proposed variants; experimental assays test their activity.
Evidence sources: https://assets-eu.researchsquare.com/files/rs-10072540/v1_covered_65be6e89-30da-488a-a7d7-0310d3a07d5f.pdf · https://www.nature.com/articles/s43588-026-01049-y
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 17 Nov 2026. Review scope: Primary Research Square v1 full-text indexed content and metadata; primary Nature Computational Science indexed article text, including abstract, Methods, experimental result, date and affiliation block..
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.
A machine-learning model that predicted antibacterial activity from biosynthetic-gene-cluster sequences prioritized Amycolatopsis azurea DSM 43854. Bioactivity-guided fractionation recovered dipyrimicins A and B from this strain, and genome analysis linked them to a previously uncharacterized dip BGC with a 76% predicted antibacterial probability; broth-microdilution assays confirmed activity against several test strains.
Technology: Machine-learning predictor of antibacterial activity from biosynthetic gene clusters
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Bioactivity-guided fractionation recovered dipyrimicins A and B from this strain, and genome analysis linked them to a previously uncharacterized dip BGC with a 76% predicted antibacterial probability; broth-microdilution assays confirmed activity against several test strains.
- Still unknown: Dipyrimicins themselves had been reported previously from a related Amycolatopsis strain; the paper’s new result is their isolation from A. azurea DSM 43854 and first linkage to its BGC, not discovery of the molecules as novel compounds. Reported antibacterial potency was moderate and tested against a few strains (for dipyrimicin A, MICs included 32 µg/mL for B. spizizenii and 64 µg/mL for S. aureus; >128 µg/mL for P. aeruginosa). Proposed functions of some tailoring genes remain speculative.
- AI role: The model ranked biosynthetic clusters and prioritized A. azurea DSM 43854 for experimental work. Researchers performed bioactivity-guided fractionation, isolated the compounds, linked them to the previously uncharacterized dip BGC, and tested antibacterial activity. The dip BGC was absent from the model’s training set, providing an out-of-training-set test of the prioritization approach.
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13122635/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.